GLP-1 receptor agonist

GLP-1 receptor agonist

Topic

Heard in 22 episodes across 9 shows since Jun 2026

GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone to lower blood sugar levels, reduce appetite, and slow digestion. They are widely used in the treatment of type 2 diabetes and obesity, and are under study for other metabolic conditions. Common examples of this drug class include semaglutide, liraglutide, and tirzepatide.

Learn more

Episodes

22
across 9 shows

First heard

Jun 2026

Expert statements

55
29 positive · 20 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20266
Jul 20265
Aug 20267
Sep 20264
Oct 20260

What experts have said about GLP-1 receptor agonist

55 statements · 29 positive · 20 negative · 4 mixed · 2 neutral

  1. Melissa TranPositiveOct 7, 2026· CNBC's "Fast Money"

    GLP-1 users’ cells show slower biological aging than non-users’ cells.

    “the biological age of the cells, it ages slower than those people not on a GLP-1.”

    Listen at 39:02

    Open the episode · Rates Back On The Rise… And Used Car Market Shifting Into Reverse 10/7/26
  2. Alexander Wissner-GrossPositiveOct 3, 2026· Moonshots with Peter Diamandis

    GLP-1 drugs can address behavioral causes of some illnesses and addictions.

    “they're actually addressing the cause.”

    Listen at 2:22:43

    Open the episode · Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299
  3. Jake AdlerNegativeSep 25, 2026· TBPN

    Approximately 10–15% of patients do not respond to GLP-1 drugs.

    “10 to 15 percent of patients don't respond to GLP-1s.”

    Listen at 1:48:50

    Open the episode · 4 Tech Arguments (Number 3 Will Shock You), Mansion Section, John Arnold Joins | Viswa Colluru, Jake Adler, Adam Korsunsky
See all 55 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

22 episodes featuring GLP-1 receptor agonist, newest first

See all 22 episodes →
GLP-1 receptor agonist · PodLume